Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  
Top Ad

Find Out

How to Find One Stock with Crorepati Potential? >> READ MORE

ZYDUS LIFESCIENCES Share Price    (CADIL)

Here is the latest stock price and chart of ZYDUS LIFESCIENCES. For more details, see the ZYDUS LIFESCIENCES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jun 24, 2022 (Close)
Price (Rs)353.70 Open (Rs) 344.70 High (Rs) 354.55 Low (Rs) 344.70
% Change2.18 Volume 15,218 Value (Rs) 5,343,430 52-Week H/L 655.00 / 319.40
Live NSE Quotes Jun 24, 2022 3:29:59 PM
Price (Rs)353.00 Open (Rs) 347.50 High (Rs) 354.50 Low (Rs) 346.35
% Change1.91 Volume 622,381 Value (Rs) 218,636,221 52-Week H/L 673.70 / 342.85
Change
1 Day
2.18%
1 Month
-3.93%
3 Months
-3.73%
1 Year
-42.74%
5 Years (CAGR)*
-7.61%
10 Years (CAGR)*
-7.59%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 20.21 P/E Ratio (x) 17.50 Market Cap (Rs m) 362,097.76 P/BV (x) 2.13 Dividend Yield (%) 0.99
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

ZYDUS LIFESCIENCES Share Price Today:

ZYDUS LIFESCIENCES last traded price was up 2.2% to Rs 353.7 on the BSE. On the NSE, ZYDUS LIFESCIENCES last traded price was up 1.9% to Rs 353.0. The total volume of shares traded was 0.6 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.6%. And the benchmark S&P BSE SENSEX was at 52,728.0 (up 0.9%).

Over the last 30 days, the ZYDUS LIFESCIENCES share price is down 2.4%. And over the last one year, ZYDUS LIFESCIENCES share price is down 43.3%.

The current market capitalisation of ZYDUS LIFESCIENCES stands at Rs 362,097.76 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of March 2022, company promoters held 74.88% stake in ZYDUS LIFESCIENCES, with no shares having been pledged. To know more, check out the latest shareholding pattern of ZYDUS LIFESCIENCES.


What else is happening in the markets today? Dig in...


FAQs on ZYDUS LIFESCIENCES

What is the ZYDUS LIFESCIENCES share price today?

The last traded price of ZYDUS LIFESCIENCES was Rs 353.7 on the BSE, up 2.2% over the previous close. On the NSE, ZYDUS LIFESCIENCES last traded price was up 1.9% at Rs 353.0.

What is the market cap of ZYDUS LIFESCIENCES?

The current market capitalisation of ZYDUS LIFESCIENCES stands at Rs 362,098 m.

What is the Earnings per share (EPS) of ZYDUS LIFESCIENCES?

ZYDUS LIFESCIENCES had an EPS of Rs 20.2 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 4.5.

What is the PE Ratio and PB Ratio of ZYDUS LIFESCIENCES?

At the current price of Rs 353.7, ZYDUS LIFESCIENCES trades at a PE ratio of 17.50 while its PB ratio stands at 2.13.

What is the Dividend Yield of ZYDUS LIFESCIENCES?

For the financial year 2021, ZYDUS LIFESCIENCES declared dividend amounting to Rs 3.5 per share. At the current price of Rs 353.7, this results in a dividend yield of 1.0%.


Today's Market

Sensex Zooms 462 Points, Nifty Ends Near 15,700; Auto & FMCG Stocks Rally(Closing)

Indian share markets ended the week on a firm note tracking positive global cues.

Related Views On News

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling (Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ZYDUS LIFESCIENCES

  • Track your investment in ZYDUS LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES - TEVA PHARMA COMPARISON

COMPARE ZYDUS LIFESCIENCES WITH

MARKET STATS